Increased Expression of Myosin Light Chain Kinase mRNA Is Related to Metastasis in Non-Small Cell Lung Cancer
- 1 January 2005
- journal article
- Published by Springer Science and Business Media LLC in Tumor Biology
- Vol. 26 (3), 153-157
- https://doi.org/10.1159/000086487
Abstract
The invasiveness of tumor cells depends in large part on their motility, which in turn depends on cytoskeletal function. A major cytoskeletal component involved in cell motility is myosin II, the classical form of myosin first identified in muscle but also expressed in nonmuscle cells. Myosin II is activated by myosin light chain kinase (MLCK), which phosphorylates it on its regulatory light chain. In this context, the contribution made by MLCK to tumor cell motility and invasiveness has been investigated extensively in vitro, but clinical evidence of such a contribution has been lacking. In the present study, therefore, we examined the role of MLCK in the metastasis of non-small cell lung cancer (NSCLC) in a clinical setting. We measured MLCK mRNA expression in tumor samples from 39 NSCLC patients using real-time semiquantitative reverse transcription polymerase chain reaction carried out in a LightCycler. We then correlated MLCK mRNA expression with known clinicopathological factors. We found that levels of MLCK mRNA expression were higher in patients who showed disease recurrence and distant metastasis than in those who did not. Moreover, the 3-year disease-free survival rate among patients showing lower levels of MLCK mRNA expression [log10(MLCK/GAPDH) or =1.4] (87.5 vs. 50.0%; log-rank test, p = 0.021). These findings are the first clinical evidence that expression of MLCK is correlated with disease recurrence and distant metastasis in NSCLC.Keywords
This publication has 14 references indexed in Scilit:
- Expression of seven main Rho family members in gastric carcinomaBiochemical and Biophysical Research Communications, 2004
- Clinical Significance of Cellular Distribution of Moesin in Patients with Oral Squamous Cell CarcinomaClinical Cancer Research, 2004
- Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin PhosphatasePhysiological Reviews, 2003
- Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chainProstate Cancer and Prostatic Diseases, 2003
- Expression and significance of RhoC gene in hepatocellular carcinomaWorld Journal of Gastroenterology, 2003
- Small GTP‐binding Protein, Rho, Both Increased and Decreased Cellular Motility, Activation of Matrix Metalloproteinase 2 and Invasion of Human Osteosarcoma CellsJapanese Journal of Cancer Research, 2001
- EFFECTS OF BRADYKININ ON CYTOPLASMIC CALCIUM AND MOTILITY IN MURINE BLADDER TUMOR CELLSJournal of Urology, 2001
- Treatment Strategies for Metastatic Non–Small-Cell Lung CancerClinical Lung Cancer, 1999
- A Single Human Myosin Light Chain Kinase Gene (MLCK; MYLK)Transcribes Multiple Nonmuscle IsoformsGenomics, 1999
- Rho proteins induce metastatic properties in vivoOncogene, 1997